Skip to main content
LSTA
NASDAQ Life Sciences

Lisata Therapeutics 与 Kuva Labs 达成最终协议被收购

feedReported by Dow Jones Newswires
Sentiment info
Positive
Importance info
9
Price
$4.18
Mkt Cap
$36.871M
52W Low
$1.81
52W High
$4.892
Market data snapshot near publication time

summarizeSummary

Lisata Therapeutics 已与 Kuva Labs, Inc. 达成最终协议被收购。这个重大发展是在 2026 年 2 月 27 日最近的 8-K 文件之后，该文件指出两家公司将延长收购条款至 2026 年 3 月 7 日。最终协议代表了与之前条款的一个重大进展，确认了交易。这一消息对 LSTA 股东有着重大影响，因为收购从根本上改变了公司的轨迹，通常会导致股票价格调整以接近协议的收购价格。交易者现在将关注协议的具体条款，包括每股收购价格以及任何监管或结算条件。

在该公告发布时，LSTA的交易价格为$4.18，交易所为NASDAQ，所属行业为Life Sciences，市值约为$3687.1万。 52周交易区间为$1.81至$4.89。 这则新闻被评估为积极市场情绪，重要性评分为9/10。 来源：Dow Jones Newswires。

show_chartPrice Chart

Share this article

Copied!

feed LSTA - Latest Insights

LSTA
Apr 15, 2026, 4:03 PM EDT
Filing Type: SC14D9C
Importance Score:
9
Tender Offer for Lisata Therapeutics Acquisition Fails to Commence by Extended Deadline
Sentiment: Negative
View Wiseek Article
LSTA
Apr 15, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
9
Kuva Labs Fails to Launch Lisata Therapeutics Tender Offer, Seeks New Financing Amid Deal Uncertainty
Sentiment: Negative
View Wiseek Article
LSTA
Apr 15, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Merger Tender Offer Delayed Indefinitely Amid Financing Uncertainty
Sentiment: Negative
View Wiseek Article
LSTA
Apr 02, 2026, 8:42 PM EDT
Filing Type: 8-K
Importance Score:
7
Lisata Therapeutics and Kuva Labs Extend Tender Offer Commencement Date for Merger
Sentiment: Neutral
View Wiseek Article
LSTA
Mar 12, 2026, 4:07 PM EDT
Filing Type: 10-K
Importance Score:
9
Lisata Therapeutics Confirms Acquisition by Kuva Labs for $5.00 Cash Plus $1.00 CVR, Resolving Going Concern
Sentiment: Positive
View Wiseek Article
LSTA
Mar 09, 2026, 7:43 AM EDT
Source: Wiseek News
Importance Score:
9
Lisata Therapeutics to Be Acquired by Kuva Labs for $5.00 Cash Plus $1.00 CVR
Sentiment: Positive
View Wiseek Article
LSTA
Mar 09, 2026, 7:39 AM EDT
Filing Type: 8-K
Importance Score:
9
Lisata Therapeutics to be Acquired by Kuva Labs for $5.00 Cash Plus $1.00 Contingent Value Right
Sentiment: Positive
View Wiseek Article
LSTA
Mar 06, 2026, 6:15 PM EST
Source: Dow Jones Newswires
Importance Score:
9
Lisata Therapeutics Enters Definitive Agreement to Be Acquired by Kuva Labs
Sentiment: Positive
View Wiseek Article
LSTA
Feb 27, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
7
Lisata Therapeutics Extends Acquisition Term Sheet with Kuva Labs
Sentiment: Neutral
View Wiseek Article
LSTA
Jan 27, 2026, 8:27 AM EST
Filing Type: 8-K
Importance Score:
7
Lisata Therapeutics Terminates Major Certepetide Licensing Agreement with Qilu Pharmaceutical
Sentiment: Neutral
View Wiseek Article